Association between alcohol consumption and subclinical atrial fibrillation

Table 1 Baseline characteristics before and after propensity score matching

	Pre-propensity score matching				Post-propensity score matching
	Non-alcohols (n = 394)	Alcohols (n = 73)	P	SMD	Non-alcohols (n = 78)	Alcohols (n = 51)	P	SMD
Demographics
Age, years	73.0 (65.0–79.0)	68.0 (61.0–74.0)	< 0.01	0.46	68.5 (63.0–77.0)	69.0 (62.0–75.5)	0.70	0.08
Male sex	116 (29.5)	62 (84.9)	< 0.01	1.35	56 (71.79)	40 (78.43)	0.52	0.15
Body mass index, kg/m²	23.9 (22.0–25.7)	24.4 (22.5–27.0)	0.09	0.18	24.2 (22.5–25.7)	23.8 (22.1–25.9)	0.82	< 0.01
Comorbidities
Hypertension	259 (65.7)	51 (69.8)	0.58	0.09	56 (71.7)	33 (64.7)	0.51	0.15
Diabetes mellitus	112 (28.4)	16 (21.9)	0.32	0.15	21 (26.9)	12 (23.5)	0.82	0.08
Dyslipidemia	119 (30.3)	18 (24.6)	0.40	0.13	20 (25.6)	13 (25.4)	1.00	< 0.01
Previous MI	13 (3.3)	0 (0.0)	0.24	0.26	78 (100.0)	51 (100.0)	NA	< 0.01
Congestive heart failure	25 (6.3)	2 (2.7)	0.35	0.17	3 (3.8)	2 (3.9)	1.00	< 0.01
Ischemic stroke or TIA	40 (10.1)	4 (5.4)	0.30	0.17	6 (7.6)	3 (5.8)	0.97	0.07
Vascular disease	6 (1.5)	4 (5.4)	0.09	0.22	1 (1.2)	0 (0.0)	1.00	0.16
Chronic kidney disease	33 (8.3)	5 (6.8)	0.84	0.06	4 (5.1)	4 (7.8)	0.80	0.11
Echocardiographic parameters
LA AP diameter, mm	40.0 (35.0–45.0)	41.3 (38.0–46.2)	0.07	0.06	41.0 (36.6–45.8)	41.8 (37.3–47.0)	0.53	0.09
LA volume index, mL/m²	40.1 (31.9–53.3)	38.2 (31.9–48.4)	0.63	0.15	40.3 (33.8–50.6)	38.6 (31.5–51.0)	0.83	0.02
LVEF, %	66.0 (61.0–71.0)	63.8 (58.7–69.0)	0.11	0.18	66.0 (60.0–69.3)	63.8 (58.1–69.0)	0.44	0.10
E/E’	11.6 (8.4–15.0)	11.2 (8.9–13.7)	0.56	0.16	11.5 (9.0–14.9)	11.0 (8.3–13.9)	0.40	0.23

Values are reported as interquartile range, number (%) unless otherwise indicated
SMD Standardized mean difference; MI Myocardial infarction; TIA Transient ischemic attack; LA Left atrium; AP Anteroposterior; LVEF Left ventricular ejection fraction

ISSN: 2466-1171